Exposure to endocrine-disrupting chemicals (EDCs) during fetal and neonatal periods can have toxic effects that are irreversible and last a lifetime. However, the mechanism underlying this phenomenon is still unknown. Here, we show the effect of 17alpha-ethynyl estradiol (EE) on the development of the primordial follicle during early ovarian development in female rats. Microarray analysis revealed the down-regulation of Hrk, an activator of apoptosis, in neonatal ovaries exposed to EE. Real-time PCR analysis also showed a decrease of Hrk mRNA expression in ovaries treated with EE both in vitro and in neonatal rats. An immunostaining assay showed that HRK protein and cleaved caspase 3 colocalize in the oocytes at Postnatal Day 1 (PND1). The EE-exposed ovaries had a reduced number of oocytes positive for TUNEL staining compared to control ovaries at PND1. Abnormal follicle formation of EEexposed ovaries was observed at PND7 and PND21. A TUNEL staining assay revealed that Hrk depletion reduced the number of apoptotic oocytes. In addition, down-regulation of Hrk mRNA expression was observed in ovaries treated with other estrogenic chemicals. We propose a model in which EE inhibits oocyte apoptosis in the neonatal ovary by suppressing the expression of Hrk, thereby disrupting follicle formation and ovary function.
INTRODUCTION
A major function of the ovary is to supply oocytes for periodic ovulation in reproductive animals. This process is intricately related to oogenesis and folliculogenesis. Typically, primordial follicle formation occurs during the late fetal and early postnatal period in rodents. The process consists of the breakdown of germ cell cysts, oocyte apoptosis, and the envelopment of surviving oocytes with pregranulosa cells. As the flattened pregranulosa cells take on a cuboid shape, the primordial follicles develop into primary follicles. The single layer of granulosa cells proliferates and forms several layers, which serve as an indicator of the development of primary follicles into secondary follicles. As the follicles grow and form an antrum, the mature follicle will ovulate and eventually form the corpus luteum [1, 2] . Numerous hormones and growth factors exert positive or negative effects to tightly regulate these processes, and estrogen is known to be a central regulator.
The high rate of oocyte death has been observed at the perinatal ovaries in many different species [3] [4] [5] [6] [7] . During the process of germ cell cyst breakdown, oocyte apoptosis has been shown to be linked to primordial follicle formation in the perinatal ovaries [8] [9] [10] . At the perinatal period in rodents, estrogen levels drop as oocytes undergo apoptosis [6, 11] . Fetal ovaries undergo a great amount of oocyte loss when they are removed from an environment with high estrogen levels, and oocyte loss can be reduced by the addition of estrogen [12] . Oocyte apoptosis in ovaries is substantially reduced by treatment with estradiol monobenzoate at Postnatal Day 5 (PND5) [13] . There is ample evidence suggesting that estrogenic compounds inhibit germ cell cyst breakdown and primordial follicle formation [12, [14] [15] [16] . To a great extent, the number of assembled primordial follicles determines the number of oocytes to be ovulated in the future, which may dictate the reproductive lifespan of the female.
A variety of endocrine-disrupting chemicals (EDCs) that mimic estrogenic compounds can be found in the environment, which have potentially deleterious effects on development, growth, metabolism, reproduction, and other physiological functions in animals [17] [18] [19] [20] [21] [22] [23] . The synthetic estrogen17alpha-ethynyl estradiol (EE) has been widely used as an oral contraceptive for women. It has been found in wastewater, where it can disrupt reproductive function of wild aquatic animals [24] [25] [26] [27] . Moreover, it can be absorbed and accumulated in plants, and can enter our terrestrial food supply via land-based application of water [28] . Previous studies demonstrate that neonatal exposure to EE in rats leads to long-term effects in adulthood, including a prematurely disrupted estrous cycle and a shorter reproductive lifespan [29] [30] [31] [32] [33] [34] [35] . The mechanisms for these effects are diverse and still unclear, but likely involve changes in expression levels of genes related to apoptosis and/or follicular assembly during early ovarian development.
To gain a better understanding of the mechanism driving the delayed effects of EE on female reproduction, we investigated the direct effect of EE on neonatal ovarian development. First, microarray analysis was performed on harakiri (Hrk), a proapoptotic factor, using control and EE-exposed neonatal ovaries. Second, to clarify the impact of Hrk on EE-exposed ovaries, follicular composition and apoptosis analysis were conducted. Finally, to evaluate whether the down-regulation of Hrk by EE is due to the estrogenic activity or not, other estrogenic compounds were also examined.
MATERIALS AND METHODS

Animals
Adult Wistar-Imamichi male and female rats were purchased from Institute for Animal Reproduction and were maintained at 23 6 28C under a 14L:10D schedule (lights on 0500-1900 h) with free access to food and tap water. The estrous cycles of female rats were monitored by vaginal cytology, and they were mated with male rats at proestrus. All experiments with rats were performed according to the guidelines of the Institutional Animal Care and Use Committee of Tokyo University of Agriculture and Technology (23-1). Figure 1 summarizes the in vivo and in vitro experiments conducted. In vivo experiments. Newborn female pups received a single s.c. injection of sesame oil vehicle (Sigma-Aldrich) or EE (200 lg/kg; Sigma-Aldrich) in the nape of the neck within 24 h of delivery at PND0. Ovaries in control and EE treatment groups were collected at PND1 (n ¼ 8), PND3 (n ¼ 5), PND7 (n ¼ 5), PND14 (n ¼ 5), and PND21 (n ¼ 5). One ovary from each rat was snap frozen for RNA extraction and the other was fixed in 4% paraformaldehyde for histological analysis. To explore key genes affected by EE treatment, ovaries at PND1 were used for microarray analysis.
Experiment Design
In vitro experiments. Ovaries were collected from intact pups at PND0 and cultured with varying doses of EE (0.1, 1, 10, and 100 nM), or different estrogenic chemicals (17beta-estradiol [E2; Sigma-Aldrich], EE, or diethylstilbestrol [DES; Sigma-Aldrich]; 10 nM each) in Dulbecco modified Eagle medium high glucose without phenol red (Invitrogen) containing insulintransferrin-selenium supplement (Invitrogen) and antibiotic-antimycotic (Invitrogen). The control group was cultured with the same amount of dimethyl sulfoxide (DMSO; Wako) and all chemicals were dissolved in 0.05% DMSO. After 24 h, cultured ovaries were snap frozen for real-time PCR analysis. A sample size of five was selected for each treatment group.
Microarray Analysis
Total RNA was isolated from ovaries of control and EE treatment at PND1 (n ¼ 5 in each group), and pooled RNA was used for microarray analysis. An aliquot of 1 lg of total RNA was used to synthesize double-stranded cDNA, and biotin-labeled cRNA was amplified from cDNA. Finally, cRNA was hybridized to a GeneChip Rat Genome 230 2.0 Array (Affymetrix) for 16 h at 458C. After hybridization, chips were washed and dried and then scanned by the GeneChip Scanner 3000 (Affymetrix).
Gene ontology (GO) term enrichment analysis was performed using the rat genome database Web site tools (http://amigo.geneontology.org/). The cutoff P value is 0.001.
Real-Time PCR Analysis
Total RNA was extracted from ovaries using TRIzol Reagent (Invitrogen) according to the manufacturer's protocol. The cDNA was synthesized using PrimeScript first-strand cDNA Synthesis Kit (Takara Bio). The oligonucleotide primers for quantitative RT-PCR analysis were designed using the Primer 3 program (Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod.org). The PCR reactions were carried out in a 10-ll volume using Ex TaqR Hot Start Version containing SYBR-Green I (Takara Bio) and performed with the Chrome4 real-time PCR system (Bio-Rad) using the following conditions: 958C for 30 sec, followed by 40 cycles of 958C for 5 sec, 608C for 30 sec, and dissociation protocol. The relative expression level of each ZHANG ET AL. target mRNA was calculated by multiple internal controls including beta-actin and glyceraldehyde phosphate dehydrogenase mRNA [36] .
Histology
Ovaries were fixed in 4% paraformaldehyde, embedded in paraffin, and serially sectioned at 6 lm. To estimate the follicular composition, ovaries from PND7 and PND21 were used and every third section was stained with hematoxylin and eosin (n ¼ 3 ovaries per group). Five PND1 ovaries from each group were used for immunostaining, and three were used for TUNEL staining.
Immunohistochemistry
Sections were deparaffinized in xylene and rehydrated though a graded series of ethanol. To increase epitope exposure, the sections were heated in 0.01 M sodium citrate buffer, pH 6.0, at 1218C for 10 min in an autoclave. After incubating in 0.3% H 2 O 2 in methanol for 30 min, the sections were blocked with 10% normal goat serum for 1 h to reduce background staining caused by the second antibody. Then the sections were incubated with anti-Hrk primary antibody (#PA1-86773; Thermo Fisher Scientific) overnight at 48C. The sections were incubated with a secondary antibody, anti-rabbit IgG conjugated with biotin and peroxidase with avidin, using a rabbit VECTASTAIN ABC kit (Vector Lab), and subsequently visualized with diaminobenzidine (Nichirei Biosciences) as a chromogen substrate. Finally, the sections were counterstained with hematoxylin solution. The control sections were treated with normal rabbit IgG (Santa Cruz Biotechnology) instead of the primary antibodies. The immunohistochemical result was quantified via counting the oocytes with Hrk-positive staining.
TUNEL Staining
TUNEL staining was performed according to the manufacturer's manual using ApopTag peroxidase in situ apoptosis detection kit (Millipore). The number of positively stained oocytes was counted in every three sections.
Immunofluorescence
Double staining for Hrk and cleaved caspase 3 was performed using Opal 4-color fluorescent IHC kit (PerkinElmer) according to the modified manual. Deparaffinized and rehydrated sections were blocked with 10% normal goat serum for 1 h and then incubated with Hrk antibody (1:200; #PA1-86773; Thermo Fisher Scientific) overnight at 48C. Horseradish peroxidase-conjugated secondary antibody was applied for 1 h and the coloring step was performed according to the manual by Opal-520 amplification reagent. The slides were treated in the ancillary reagent buffer in a microwave according to the manual, and the same procedure was carried out for the primary antibody cleaved caspase 3 (1:200; #9661; Cell Signaling Technology) or primary antibody DDX4 (1:100; ab13840; Abcam). Opal-670 amplification reagent was used for cleaved caspase 3 or DDX4 coloring. We used 4 0 ,6-diamidino-2-phenylindole (DAPI) for counterstaining and the normal rabbit IgG was used instead of primary antibody as a negative control. Images were captured using an immunofluorescence microscope (BX-51; Keyence).
Plasmid Construction and Virus Infection
A lentiviral short hairpin RNA targeting rat Hrk (shHrk) was cloned into pLentiLox 3.7 vector: 5 0 -GATTCAAGAGCCAAGAAAT-3 0 . The lentiviral constructs were cotransfected with the packaging plasmids into 293T cells using lipofectamine 2000 (Invitrogen). Virus-containing supernatants were collected 48 h after transfection. The virus-containing supernatants were mixed gently with PEG solution (13 mM PEG 6000, 100 mM NaCl, 10 mM HEPES, pH 7.4) and rotated at 48C overnight. The supernatant was removed after 1500 3 g centrifuge at 48C for 30 min, and 1 ml opti-MEM medium (Invitrogen) was added into the virus. The concentrated virus was kept at À808C until use.
Neonatal ovaries were collected from intact pups at PND0 and infected with virus-containing supernatant in opti-MEM. After 24 h, ovaries were subjected to real-time PCR and TUNEL staining (n ¼ 5 each group for each experiment).
Statistical Analysis
Statistical comparisons were made with the Student t-test, one-way ANOVA followed by conservative Tukey test, or two-way ANOVA followed by Sidak multiple comparisons test using Prism 5 (Graphpad Software Inc.). A value of P , 0.05 was used as an indication of statistical significance.
RESULTS
Profile of Gene Expression in Neonatally EE-Exposed Ovary
Of the 30 000 genes examined between control and EEexposed ovaries, changes in mRNA levels were detected in 545 genes: 235 of those were increased (over 2-fold), and 310 were decreased (less than 0.5-fold) (Supplemental Tables S2 and S3 , respectively). The five genes with the most increased or decreased expression identified by the microarray examination were validated with real-time PCR analysis ( Table 1 ). The GO term enrichment analysis revealed that the differentially expressed genes were highly associated with apoptosis (Supplemental Table S4 ). Of note, one particular proapoptotic gene, Hrk, was significantly decreased in expression in the EEexposed ovaries (Table 1) .
Down-Regulation of Hrk Expression in Neonatal EEExposed Ovary
To confirm the involvement of Hrk in early ovarian development, Hrk mRNA expression was measured by realtime PCR from ovaries collected from control and EE-exposed pups at PND1, PND3, PND7, PND14, and PND21 (Fig. 2a) . In control animals, high expression of Hrk mRNA was observed at PND1 and decreased from PND3 to PND21. However, in EE DISRUPTS OOCYTE APOPTOSIS vivo exposure to EE at PND0 suppressed the Hrk mRNA expression in ovaries at PND1. Next, ovaries were collected from pups at PND0 and cultured with EE for 24 h in vitro, and we found that the expression of Hrk mRNA was significantly decreased (Fig. 2b) . This suggests that EE exposure can directly decrease the expression of Hrk mRNA in neonatal ovaries. Immunohistochemical analysis revealed that the Hrk protein was expressed in oocytes at PND1, and it had a weaker staining in the EE-exposed ovaries compared to control (Fig. 2,  c and d) . The Hrk-positive-stained oocytes were decreased in the EE-exposed ovaries compared to control (Fig. 2e) .
Colocalization of Hrk and Cleaved Caspase 3 in Neonatal Ovary
Because Hrk is a known proapoptotic factor, we stained for both Hrk and cleaved caspase 3 in control and EE-exposed ovaries (Fig. 3a) . In control ovaries, Hrk and cleaved caspase 3 were highly colocalized in the oocytes; however, in EEexposed ovaries, Hrk had a weaker expression and a reduced colocalization with cleaved caspase 3. Moreover, the colocalization of Hrk and oocyte marker DDX4 was confirmed in the ovaries of PND1 (Fig. 3b) , suggesting Hrk was localized in the oocytes of neonatal ovaries.
Decrease of Apoptosis of Oocytes and Number of Primordial Follicles in Neonatal EE-Exposed Ovaries
We performed a TUNEL staining assay to quantify the number of apoptotic oocytes in control and EE-exposed ovaries (Fig. 4, a and b) . There was a decreased number of oocytes with positive TUNEL staining in EE-exposed ovaries at PND1 (Fig. 4c) .
The histological results of ovary staining at PND7 are shown in Figure 4e . The primary follicle is represented by the oocyte surrounded by cubical granulosa cells, the primordial follicle is represented by the oocyte surrounded by squamous granulosa cells, and the oocyte that is not surrounded by any 
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granulosa cells represents the oocytes in the germ cell cyst. The total number of different types of follicles was counted in the control and EE-exposed ovaries at PND7. There was a decrease in the number of primordial follicles in the EE-exposed ovaries compared with control ovaries (Fig. 4d) .
Histological analysis in control and EE-exposed ovaries at PND21 was also investigated. We observed the presence of multiple oocyte follicles in exposure to several EDCs [37] [38] [39] . Indeed, the multiple oocyte follicles were found and increased in the ovaries of EE-exposed animals (Fig. 4, f and g ).
Effect of Hrk Knockdown in Neonatal Ovary
Neonatal ovaries at PND0 were infected with lentiviruses expressing GFP only (control) or GFP plus shHrk. Similar GFP expression was observed in both ovaries, and the expression of Hrk gene decreased more than 40% in shHrk-treated ovaries (Fig. 5, a-c) . There was a decreased number of apoptotic oocytes in Hrk knockdown ovaries compared to control ovaries (Fig. 5, d-f) . We confirmed that the GFP signal was bleached before the process of TUNEL staining (data not shown).
Down-Regulation of Hrk Expression by Estrogenic Compounds
To evaluate the effect of estrogenic compounds on the expression of Hrk in the ovary, the ovaries were cultured with E2 and DES, and the expression of Hrk was analyzed by realtime PCR. The expressions of Hrk in ovaries treated with E2 or DES were decreased to a similar extent as ovaries treated with EE (Fig. 6) . These results indicate that the expression of Hrk could be used as a screening marker for the early effect of estrogenic compounds on ovarian development.
DISCUSSION
We are frequently exposed to several types of EDCs. The increasing health risk associated with exposure to EDCs has become an increasing cause for concern. EE, which is commonly prescribed for estrogen replacement therapy, has been found to influence sexual development and behavior in aquatic wildlife through environmental contamination [24] . Studies performed in rats also show that EE can induce an abnormal estrous cycle and other reproductive dysfunctions [29] [30] [31] [32] . Moreover, once leaked into the environment to EE DISRUPTS OOCYTE APOPTOSIS contaminate aquatic and/or terrestrial food supplies, EE could pose a health risk for humans.
Although some research concerning the effect of estrogenic compounds on ovarian development has been reported [12, [14] [15] [16] , the mechanism has remained unclear until now. The link between cell apoptosis and EE has been reported in different tissues [40, 41] . Interestingly, the present microarray results confirmed EE regulated many genes related to cell apoptosis, suggesting that EE may regulate cell apoptosis in ovaries. The Bax-deficient animal model and the relationship between Bcl2 family members in the mitochondria membrane and oocyte apoptosis suggest the Bcl2 family may be involved in oocyte apoptosis during follicle assembly [8, 42] . In this study, we present another Bcl2 family member, Hrk, in the key gene for oocyte apoptosis. The colocalization of Hrk and the wellknown apoptotic factor cleaved caspase 3 in the oocytes indicates Hrk may interact with the activated caspase 3. Further, the number of apoptotic oocytes was also decreased in the Hrk knockdown ovaries, which suggests Hrk is responsible for oocyte apoptosis. Moreover, the expression of Hrk in the ovary was decreased by EE exposure, along with the decreased apoptotic oocytes. Taken together, the results suggest that Hrk is a key target gene in the EE-exposed ovaries, and decreased expression of Hrk by EE exposure leads to the reduction of oocyte apoptosis in early ovarian development.
We found the putative estrogen-responsive element (ERE) located in the promoter region of Hrk gene (Supplemental Fig.  S1 ), which indicates that EE or estrogens could directly regulate Hrk gene expression via ERE-dependent pathway. In theory, estrogen receptors (ERs) may bind with ERE, which recruits corepressors and suppress Hrk gene expression. Alternatively, EE may affect Hrk expression through differentially regulating the expression of ERs. In this study, the expression of ERa is suppressed significantly at PND1 in the EE-exposed ovaries; however, ERb is not affected by EE exposure (Supplemental Fig. S2 ). These data indicate that EE may regulate the balance of ERa and ERb expression. Previous reports showed ERb would act as ERa antagonist and oppose the ERa-mediating gene expression [43, 44] . The type of ER dimer binding with ERE in Hrk gene may be altered because of c) The average number of positively stained oocytes per paraffin section for TUNEL staining in control and EE-exposed ovaries at PND1. Asterisk denotes statistical significance (P , 0.05). d) The total number of different types of follicles in rat ovaries at PND7. Ovaries of EE-treated animals had a decreased number of primordial follicles. Asterisk denotes statistical significance (P , 0.05). e) A histological analysis reveals the different types of follicles present. Asterisk denotes statistical significance (P , 0.05). f) The percentage of multi-oocyte follicles increased in EE-treated ovaries at PND21. Asterisk denotes statistical significance (P , 0.05). g) The histology of multi-oocyte follicles present in EE-treated ovaries at PND21. Bar ¼ 100 lm.
ZHANG ET AL.
the decreased expression of ERa, which results in the decreased expression of Hrk. Further confirmation of the mechanism of how EE disrupts Hrk expression in the neonatal ovary needs to be done.
In the fetal or neonatal ovary, oocyte apoptosis occurs during the germ cell cyst breakdown and primordial follicle assembly, which is an important process for follicle formation. Previous studies show that neonatal exposure to estradiol or phytoestrogen (genistein) leads to the inhibition of oocyte nest breakdown and primordial follicle formation in rodent ovaries [12, 14, 16] . Consistent with this, the present study showed that EE exposure to the neonatal ovaries decreased oocyte apoptosis in PND1 ovaries and primordial follicle number in PND7 ovaries. This calls into question the nonapoptotic oocytes in the EE-exposed ovaries. According to previous reports, abnormal follicle formation and multi-oocyte follicles were found in ovaries exposed to other estrogenic chemicals [12, 38, 39] . Based on this, we proposed that the nonapoptotic oocytes might form abnormal follicles in the EE-exposed ovaries. To test this, the histology of EE-exposed ovaries at PND21 was examined. As expected, there was an increased number of multi-oocyte follicles in the EE-exposed ovaries at PND21. The multi-oocyte follicle with antrum was present at PND21 (Fig. 4F) , indicating those kinds of follicles have the capacity EE DISRUPTS OOCYTE APOPTOSIS to grow and develop. Based on the ovarian histology at PND90, there is no multi-oocyte follicle observed in the EEexposed ovaries [31] . Therefore, the fate of those multi-oocyte follicles is still unclear. A question of whether they undergo ovulation or apoptosis during development remains open. In our previous study, the irregular estrous cycle and earlier ceased estrous cycles were observed in the EE-exposed animals [31] . Though there is no direct evidence in the present study, the multi-oocyte follicles are suspected to be one reason for this phenomenon. Moreover, the in vitro experiments showed the fertilization ratio decreased in the oocytes from multi-oocyte follicles, indicating the quality of oocytes from multi-oocyte follicles is poor [45] . And the presence of multi-oocyte follicles may induce the reproductive repercussions by shortening the reproductive lifespan of the female [46] .
It has been established that the so-called delayed effect of fetal or neonatal exposure to estrogenic compounds causes reproductive defects that appear in adulthood [18] . In our previous studies, neonatal exposure to EE in rats resulted in an abnormal estrous cycle in early adulthood and a decreased number of primordial follicles at PND90 [31] . In the present study, we found that neonatal exposure to EE disrupted oocyte apoptosis at PND1 and decreased primordial follicle formation at PND7. Also, the nonapoptotic oocytes formed multi-oocyte follicles in PND21 ovaries. Combining these results, we propose that the decreased oocyte apoptosis and disrupted follicle assembly in ovaries by neonatal exposure to EE may cause abnormal ovarian function in adulthood.
In the present study, neonatal exposure to EE inhibited oocyte apoptosis in ovaries. However, this phenomenon was not only observed in EE-treated animals. Neonatal exposure to another synthetic estrogen, DES, can also reduce oocyte apoptosis in C57BL/6J mice [47] . Also, PND5 mouse ovaries had substantially reduced apoptotic oocytes after neonatal treatment with estradiol monobenzoate [13] . This suggests that these estrogenic chemicals may use a similar mechanism to inhibit oocyte apoptosis at an early stage of ovarian development. Indeed, the in vitro data show that E2 and DES can also suppress the expression of Hrk in the cultured ovaries. Furthermore, although there are limited case numbers on human studies, maternal smoking reduced human fetal ovarian cell numbers and Hrk as one of the target genes was dysregulated [48] . Maternal exposure to 1 mg/kg polycyclic aromatic hydrocarbons (PAHs) for 3 wk (the accumulation of PAHs is equivalent to 25 packages of cigarettes, consistent with potential exposure in a heavy smoker) would reduce the pup's ovarian follicle pool via Hrk-mediating pathway in mice [49] . Taken together, the results suggest Hrk could be a key target of estrogenic chemicals in the ovary, and Hrk could serve as a screening marker for the effect of the estrogenic chemicals on neonatal ovaries.
In conclusion, we have shown that neonatal exposure to EE directly inhibits oocyte apoptosis in the neonatal ovary by suppressing the expression of the Hrk protein, which is localized in oocytes of neonatal rat ovaries. The decreased amount of oocyte apoptosis and primordial follicles may cause an abnormal estrous cycle and other ovarian defects during adulthood.
